{
    "code": 0,
    "data": [
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Kindly refer enclosed attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b1fb71a-3c0c-494a-9efd-d86796a0cd8e.pdf",
            "news_date": "2026-02-02 17:27:08"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.",
            "news_id": "fe91fd2a-59ca-47f5-87b5-d2419454000b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b8547b-3699-4956-b982-474f88ea4a53.pdf",
            "news_date": "2026-01-30 18:43:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of Earnings Call held on 22nd January 2026 which is also made available on the website of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b8547b-3699-4956-b982-474f88ea4a53.pdf",
            "news_date": "2026-01-30 18:43:05"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Kindly refer the attachment.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3122d2fe-20fe-46c7-b6bb-78b425bccc0e.pdf",
            "news_date": "2026-01-30 17:34:47"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a127825a-b2f6-4b81-8b2c-5b80aeca31fa.pdf",
            "news_date": "2026-01-28 14:44:23"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q3 FY2025-26 Earnings Call held on January 22 2026 on the website of the Company at:\r\nhttps://www.alivus.com/alivus_pdfs/investors/financials/reports_presentation/10039101.mp3",
            "news_id": "0cb5a0b0-c6d0-48c1-8e57-eb04d193ae53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da60cf05-a6ac-4426-8c8b-c833afce6850.pdf",
            "news_date": "2026-01-22 19:59:36",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q3 FY2025-26 Earnings Call held on January 22 2026 on the website of the Company at:\r\nhttps://www.alivus.com/alivus_pdfs/investors/financials/reports_presentation/10039101.mp3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da60cf05-a6ac-4426-8c8b-c833afce6850.pdf",
            "news_date": "2026-01-22 19:59:36"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investors Presentation - Q3 FY 25-26.",
            "news_id": "a4fdd875-e32e-4265-9b45-b3c3bb00e543",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=512b006a-0a27-4139-9724-eba7013ba461.pdf",
            "news_date": "2026-01-22 14:27:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Investors Presentation - Q3 FY 25-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=512b006a-0a27-4139-9724-eba7013ba461.pdf",
            "news_date": "2026-01-22 14:27:51"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Enclosed please find herewith the Press Release on Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0200b761-5a41-4a9a-8076-7eebd55850e5.pdf",
            "news_date": "2026-01-22 14:21:40"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended 31 December 2025.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for the Third Quarter and Nine Months ended 31st December 2025.",
            "news_id": "3d36dcd3-219c-4fa0-be25-8e4e5dfdc263",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=257004bd-fe6e-47bb-99d3-c5b6b7e201a4.pdf",
            "news_date": "2026-01-22 14:05:08",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended 31 December 2025.",
            "news_body": "Please find enclosed herewith Unaudited Financial Results for the Third Quarter and Nine Months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=257004bd-fe6e-47bb-99d3-c5b6b7e201a4.pdf",
            "news_date": "2026-01-22 14:05:08"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI (LODR) 2015 we wish to inform you that the Board at its meeting held today approved the unaudited Financial Results for the Third Quarter and Nine Months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2f397c7-c226-472b-b7ba-c1a4fee23f30.pdf",
            "news_date": "2026-01-22 13:49:45"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Enclosed please find herewith intimation with respect to allotment of Equity Shares under the Employee Stock Option Scheme 2021.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=680babae-cfdd-4ad2-b2b5-6dbbe1cd0f3e.pdf",
            "news_date": "2026-01-21 19:17:12"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed please find herewith the details of Earnings Call slated for Thursday January 22 2026 from 6:00 p.m. to 7:00 p.m. (IST) for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42e2e31d-58ad-4775-9f97-b18775e10922.pdf",
            "news_date": "2026-01-15 14:18:58"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window from December 31 2025 to January 24 2026 (both days inclusive) for the purpose of approval of unaudited financial results for quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=adc92dce-fd5a-47a1-8a81-cd2eab63f2b6.pdf",
            "news_date": "2026-01-14 17:06:39"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2025.",
            "news_body": "Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ec54452-c7e2-409b-8506-bdd5c1d93cac.pdf",
            "news_date": "2026-01-14 17:00:49"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ba0d8f5-ef45-4a68-b806-a07c0f0f5bcb.pdf",
            "news_date": "2025-12-24 17:59:59"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6cbaf734-e787-4dc7-9da3-2b1b1a698028.pdf",
            "news_date": "2025-12-18 17:27:46"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=278047aa-515a-4121-b026-c3b6fb55d859.pdf",
            "news_date": "2025-12-15 16:50:36"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e615e9bf-60fe-414d-a3e6-89e3ad0b19c4.pdf",
            "news_date": "2025-12-11 16:41:38"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a8e2052-80d7-474f-ab40-55e5aba8a18a.pdf",
            "news_date": "2025-12-03 17:06:53"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022f343c-6fa4-4e6f-8934-2e81c6d596c1.pdf",
            "news_date": "2025-12-01 16:59:42"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23fce929-3904-45d7-9e67-75f50faa9e30.pdf",
            "news_date": "2025-11-27 20:53:07"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=928c5ee4-9b02-4384-8556-f49cc40ed037.pdf",
            "news_date": "2025-11-14 14:29:56"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call.",
            "news_id": "b9939b3b-6aaa-43b1-9fa6-bef27cd7e2c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f8e4217-f830-4a36-8fc3-7582ac309ce9.pdf",
            "news_date": "2025-11-13 11:43:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f8e4217-f830-4a36-8fc3-7582ac309ce9.pdf",
            "news_date": "2025-11-13 11:43:13"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q2 FY2026 Earnings Call held on November 07 2025 on the website of the Company at:\r\n\r\nhttps://bunny-wp-pullzone-zhbiessutg.b-cdn.net/alivus_pdfs/investors/financials/reports_presentation/10037134.mp3",
            "news_id": "6e27bd36-82b1-442c-a95c-94ce2eb726d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ee542a3-6cf5-4d38-ac35-528c1fe26150.pdf",
            "news_date": "2025-11-07 15:17:26",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q2 FY2026 Earnings Call held on November 07 2025 on the website of the Company at:\r\n\r\nhttps://bunny-wp-pullzone-zhbiessutg.b-cdn.net/alivus_pdfs/investors/financials/reports_presentation/10037134.mp3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ee542a3-6cf5-4d38-ac35-528c1fe26150.pdf",
            "news_date": "2025-11-07 15:17:26"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Enclosing herewith Investor Presentation - Q2 FY 2025-26.",
            "news_id": "a78b548b-381b-4a9d-9c46-697099daeabf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=456b8f18-4155-43de-b301-ca96c323a1de.pdf",
            "news_date": "2025-11-06 19:28:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Enclosing herewith Investor Presentation - Q2 FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=456b8f18-4155-43de-b301-ca96c323a1de.pdf",
            "news_date": "2025-11-06 19:28:09"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Q2 FY 2026 Financials",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59f8c453-24b6-4345-adf2-9e05eecfe8ab.pdf",
            "news_date": "2025-11-06 18:55:44"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results for the Second quarter and Half Year ended September 30 2025.",
            "news_id": "d70d9d80-a330-41a2-9679-6216287c0b2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03c976ff-796d-4b11-8cdc-6c05276745bc.pdf",
            "news_date": "2025-11-06 18:44:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30 2025",
            "news_body": "Please find enclosed Unaudited Financial Results for the Second quarter and Half Year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03c976ff-796d-4b11-8cdc-6c05276745bc.pdf",
            "news_date": "2025-11-06 18:44:05"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed please find herewith the details of Earnings Call slated for Friday November 7 2025 from 8:30 a.m. to 9:30 a.m. (IST) for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2353accd-e5d3-4438-ba65-ca2b1e230735.pdf",
            "news_date": "2025-10-30 15:46:23"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window from September 30 2025 to November 08 2025 (both days inclusive) for the purpose of approval of unaudited financial results for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e1a11c8-1d7a-447b-b832-c65c1a059cf4.pdf",
            "news_date": "2025-10-29 17:40:54"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2025.",
            "news_body": "Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bac5a5d-be12-4c40-86a5-bf174fac6750.pdf",
            "news_date": "2025-10-29 17:35:33"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General",
            "descriptor": "General",
            "caption": "Disclosure under Regulation 30 of LODR",
            "news_body": "Alivus Life Sciences Ltd has informed BSE regarding the details of Notice/Order received by the Company from Office of The Gujarat Pollution Control Board (GPCB).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=386AC5F4-468B-43CA-8BA8-93159DF4072A-094549.pdf",
            "news_date": "2025-10-20 09:45:52"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations)",
            "news_body": "Disclosure under Regulation 30 of SEBI LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=264a755d-b558-4ae4-bb6a-aba3b8344eb2.pdf",
            "news_date": "2025-10-02 11:45:59"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "India Rating upgrades Alivus Life Sciencess Bank loan facilities to IND AA ; Outlook stable.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68e45791-0c32-47e3-a6b8-1a3f04bd1461.pdf",
            "news_date": "2025-09-16 15:37:44"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached herewith intimation with respect to Appointment of Secretarial Auditor.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08d1a5f6-9d10-4296-bd99-2d1d2d445be2.pdf",
            "news_date": "2025-09-08 20:47:29"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find attached herewith Scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42e8a975-df69-4f1c-9b4e-11eda5b0eaea.pdf",
            "news_date": "2025-09-08 20:41:32"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of the 14th Annual General Meeting (AGM) of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 08th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f419f57e-c383-4cfb-968f-5c1abfc121f6.pdf",
            "news_date": "2025-09-08 20:35:54"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Change In Corporate Office Address.",
            "news_body": "Change in Corporate Office address.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14c9cbc9-1f82-4ca1-86eb-5df471f911f9.pdf",
            "news_date": "2025-09-03 17:44:44"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4cda321-c6c5-42d5-81a6-63eb2ce8cba4.pdf",
            "news_date": "2025-08-26 11:34:30"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7225d685-5af9-481f-bf2e-0e97ad9bb7d8.pdf",
            "news_date": "2025-08-21 15:16:50"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "GENERAL",
            "caption": "Disclosure under Regulation 30A of LODR",
            "news_body": "Disclosure under Regulation 30A of LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70e23902-4bef-4ee5-8767-0a3b0b654246.pdf",
            "news_date": "2025-08-20 14:21:07"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement of Notice of 14th Annual General Meeting and E voting information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a3c5e97-ea98-4940-8f18-9250eaa9b48f.pdf",
            "news_date": "2025-08-15 17:02:52"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Business Responsibility & Sustainability Report For FY 2024-25",
            "news_body": "Business Responsibility & Sustainability Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4ddbeff-f9e1-43c8-9747-6f68e97a07bc.pdf",
            "news_date": "2025-08-12 16:18:44"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Submission of Integrated Annual Report under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daaf54ff-eb86-4644-8715-0b30eac8e16e.pdf",
            "news_date": "2025-08-12 15:51:11"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 14Th Annual General Meeting Of The Company For FY 2024-25 As Required Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Notice of 14th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b2f3d97-188f-4d2e-8372-758737a137ff.pdf",
            "news_date": "2025-08-12 15:42:13"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for 14th Annual General Meeting (AGM)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f217b51-f70b-454c-a91c-eafaff0572b9.pdf",
            "news_date": "2025-08-12 15:24:40"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": " Intimation Of Record Date For Dividend",
            "news_body": "Intimation of Record Date for Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01a8cda1-ca2a-4d2e-90d9-428337943ce0.pdf",
            "news_date": "2025-08-11 11:00:51"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of 14Th Annual General Meeting And Record Date",
            "news_body": "Intimation of 14th Annual general Meeting and Record date",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=596753ce-9b1a-44d5-b6e4-5b9a8b87a845.pdf",
            "news_date": "2025-08-11 10:57:37"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call",
            "news_id": "afc12b25-ec0e-4863-8412-2c18d69090eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2b02e0-9dd7-45cf-9b7e-36dd0e85829a.pdf",
            "news_date": "2025-08-08 16:55:29",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed please find Transcript of Earnings Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af2b02e0-9dd7-45cf-9b7e-36dd0e85829a.pdf",
            "news_date": "2025-08-08 16:55:29"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith Analyst/ Investors Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d50837b-10b2-4357-88b0-fd689e8c951d.pdf",
            "news_date": "2025-08-04 17:49:43"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2025-26 Earnings Call",
            "news_id": "e36106aa-d341-483c-bd8e-08b955fd20a7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6caea94-c20b-45cd-b0c4-d48165f6619a.pdf",
            "news_date": "2025-08-02 12:24:11",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2025-26 Earnings Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6caea94-c20b-45cd-b0c4-d48165f6619a.pdf",
            "news_date": "2025-08-02 12:24:11"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0089a59-97c4-45f3-ba2f-a26702df00d3.pdf",
            "news_date": "2025-08-02 12:19:24"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "2781b590-687f-4ada-842e-148468277611",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c28a52f-fa3c-4117-9f2f-6a4cb2351915.pdf",
            "news_date": "2025-08-01 19:14:42",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c28a52f-fa3c-4117-9f2f-6a4cb2351915.pdf",
            "news_date": "2025-08-01 19:14:42"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached herewith Press Release.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcf0bd5a-59e6-4f65-859a-7b5a6cd5c3cf.pdf",
            "news_date": "2025-08-01 19:11:47"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Please find attached herewith Allotment of Equity Shares under the Employee Stock Option Scheme 2021",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=076f9874-5c70-403a-8994-313e9f4d2ca3.pdf",
            "news_date": "2025-08-01 19:05:41"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30 2025",
            "news_body": "Please find attached herewith Unaudited Financial Results for the First Quarter Ended 30 June 2025",
            "news_id": "7ef95d44-7f4c-4215-a1dd-64fd80c97a01",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=698425f2-b287-4aa8-9ee0-db5d3dc8b678.pdf",
            "news_date": "2025-08-01 19:01:12",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30 2025",
            "news_body": "Please find attached herewith Unaudited Financial Results for the First Quarter Ended 30 June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=698425f2-b287-4aa8-9ee0-db5d3dc8b678.pdf",
            "news_date": "2025-08-01 19:01:12"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The First Quarter Ended June 30 2025",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR 2015 we wish to inform you that the Board at its meeting held today approved the unaudited Financial Results for the First Quarter ended June 30 2025.\r\n\r\nThe said meeting of the Board commenced at 5.00 p.m. and concluded at 5.50 p.m.\r\n \r\nThe copy of the said results and Limited Review Report of the Auditor is enclosed herewith. These are also being made available on the website of the Company at www.alivus.com\r\n\r\nYou are requested to take the same on record.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ff63fca-a731-421a-b285-335cba762a33.pdf",
            "news_date": "2025-08-01 18:31:10"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30795c97-cec9-49ad-a877-1266eca66711.pdf",
            "news_date": "2025-07-26 16:29:08"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Please find enclosed Voting results of the business transacted through postal ballot as required under Regulation 44(3) of Listing Regulation along with scrutinizers Report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a26f5a05-d48f-4856-a83d-ebc82ee80f02.pdf",
            "news_date": "2025-07-24 19:47:32"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Please find enclosed Voting results of the business transacted through the Postal Ballot as required under Regulation 44(3) of the Listing Regulations and Scrutinizers report.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec25efde-e07c-4cd8-8e3c-22ea0d3dc353.pdf",
            "news_date": "2025-07-24 19:44:22"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed please find herewith the details of Earnings Call slated for Saturday August 02 2025 at 8:30 a.m. - 9:30 a.m. (IST) for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c636d60-2dc8-4b69-9c3b-19db62f79356.pdf",
            "news_date": "2025-07-24 19:34:11"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Enclosing herewith intimation with respect to closure of trading window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc997827-948c-4187-9318-3f376090d58b.pdf",
            "news_date": "2025-07-24 16:59:25"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2025.",
            "news_body": "Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve to consider and approve the Unaudited Financial Results for the quarter ended 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0448c908-c2d8-4b0e-92b6-17015d6dabc0.pdf",
            "news_date": "2025-07-24 16:53:30"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith Newspaper Publication.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c385c905-a014-4a2b-8dfb-52bc0f8366b4.pdf",
            "news_date": "2025-06-24 12:54:30"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Intimation regarding Notice of Postal Ballot - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f58c0c0-25ce-4edc-a64b-24b245fdd232.pdf",
            "news_date": "2025-06-23 17:06:45"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find enclosed herewith intimation for Analyst/ Investor Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=272f3023-891b-4d02-b468-a0185ff45f31.pdf",
            "news_date": "2025-06-09 17:06:13"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith intimation for Analyst/ Investor Meet.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c90932d-c7ef-48d0-ab98-e71b76177061.pdf",
            "news_date": "2025-05-30 17:19:10"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdb6d2b2-9faa-47db-b0f3-f3ed3ca6d04b.pdf",
            "news_date": "2025-05-30 11:23:10"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith Earnings Call Transcript.",
            "news_id": "1d99986d-9a45-4239-aa0d-cc372c77082d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79318563-47a8-499a-990a-1e34b991aea7.pdf",
            "news_date": "2025-05-23 16:08:33",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith Earnings Call Transcript.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79318563-47a8-499a-990a-1e34b991aea7.pdf",
            "news_date": "2025-05-23 16:08:33"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e5b4688-dbaf-4e1b-b67f-3fc796e14b31.pdf",
            "news_date": "2025-05-20 19:16:36"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4 & FY2024-25 Earnings Call",
            "news_id": "1d7c7f7a-5cf9-4261-8014-01a6c8497511",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ad8557d-8703-4fd4-a37c-e358335e5d40.pdf",
            "news_date": "2025-05-16 12:59:43",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4 & FY2024-25 Earnings Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ad8557d-8703-4fd4-a37c-e358335e5d40.pdf",
            "news_date": "2025-05-16 12:59:43"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclose herewith Press Release of the Company for the Fourth Quarter and Year Ended March 31 2025",
            "news_id": "3d0edec2-1b32-4e3b-a09d-62d52d71afa0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad68d0b2-95b0-496b-af6d-7f7b2325e3a8.pdf",
            "news_date": "2025-05-15 21:01:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclose herewith Press Release of the Company for the Fourth Quarter and Year Ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad68d0b2-95b0-496b-af6d-7f7b2325e3a8.pdf",
            "news_date": "2025-05-15 21:01:51"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "We are enclosing herewith the Press Release of the Company for the Fourth Quarter and Year Ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f90bf119-0953-4e9d-b950-52a3766b6df0.pdf",
            "news_date": "2025-05-15 20:55:19"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Please find attached hewith intimation with respect to Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af6cd850-c259-4ce3-972a-6f0c3edc8d8f.pdf",
            "news_date": "2025-05-15 20:51:06"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 - Change in Directore of Alivus Life Sciences Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec2755df-f16f-42d2-90f3-8e5d11e0809b.pdf",
            "news_date": "2025-05-15 20:44:56"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "This is to inform you that the Board of Directors of the Company has at its meeting held today recommended payment of Final Dividend for the Financial Year 2024-25 of Rs. 5/- (250%) per equity share of Rs. 2 each subject to the approval of shareholders at the ensuing Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5a3bf80-dbb6-4b10-bc4e-b2978d077317.pdf",
            "news_date": "2025-05-15 20:38:10"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025",
            "news_body": "Audited Financial Results for the Fourth Quarter and Year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbd496af-2876-45bd-8c96-81f8cd622552.pdf",
            "news_date": "2025-05-15 20:32:08"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025",
            "news_body": "Please find enclosed herewith Audited Financial Results for the Fourth Quarter and Year Ended March 31 2025",
            "news_id": "a10f0e76-1ecc-4ee2-a991-8aa8af57b1c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3c3165f-d4bd-4e4b-bd89-cb71e7f1cdd2.pdf",
            "news_date": "2025-05-15 20:28:27",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Fourth Quarter And Year Ended March 31 2025",
            "news_body": "Please find enclosed herewith Audited Financial Results for the Fourth Quarter and Year Ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3c3165f-d4bd-4e4b-bd89-cb71e7f1cdd2.pdf",
            "news_date": "2025-05-15 20:28:27"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed please find herewith the details of Earnings Call slated for Friday May 16 2025 at 8:30 a.m. - 9:30 a.m. (IST) for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=321d0228-3a6f-4428-9374-5cfe131a4fc6.pdf",
            "news_date": "2025-05-08 18:16:33"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "As per the Code of Conduct for Prevention of Insider Trading\" and pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its designated persons regarding closure of Trading Window from March 31 2025 to May 17 2025 (both days inclusive) for the purpose of approval of Audited Financial Results for quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc276ff6-29ee-44f8-aac5-066fbf84b773.pdf",
            "news_date": "2025-05-08 18:10:24"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for To Consider And Approve The Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2025 And To Consider And Recommend Dividend If Any On Equity Shares For The Year Ended March 31 2025.",
            "news_body": "Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2025 and to consider and recommend dividend if any on Equity shares for the year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bbf6bf1-159f-4384-bb7d-c3ee328399e0.pdf",
            "news_date": "2025-05-08 18:01:15"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Plwase find attached herewith Annual Secretarial Compliance Report for the year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1266e5a-133f-49c3-a075-7defc2cadc24.pdf",
            "news_date": "2025-05-08 15:35:28"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares under the \"Employee Stock Options Scheme 2021\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d62b7c5-f980-4eff-af73-9260c234a6f3.pdf",
            "news_date": "2025-04-30 17:25:47"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Alivus Life Sciences Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74900PN2011PLC139963</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>AA-</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>INDIA RATINGS AND RESEARCH PVT. LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rudalf Corriea <br/>  Designation: Compliance officer and Company Secretary <br/> EmailId: complianceofficer@alivus.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Tushar Mistry <br/> Designation: Chief Financial Officer <br/> EmailId: complianceofficer@alivus.com</div> </div> <div> <br/> Date: 17/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bc65745-8c7e-42e4-9d63-225d2ce800c9.pdf",
            "news_date": "2025-04-17 14:45:50"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c0b80b2-78b9-4722-8f92-375518ec37cf.pdf",
            "news_date": "2025-04-03 19:26:10"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation of Share Purchase cum Subscription Shareholders Agreement and Power Supply Agreement between Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) and Torrent Urja 19 Private Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=251bf381-6647-4176-ac15-c4219ed7e84f.pdf",
            "news_date": "2025-04-02 16:30:45"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares under the Glenmark Life Sciences Limited - Employee Stock Option Scheme 2021.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=527c6272-c55a-44e0-b988-b44035e13226.pdf",
            "news_date": "2025-03-07 16:58:51"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9479d71a-28d0-4b4f-a9a3-fb3b3d805696.pdf",
            "news_date": "2025-03-03 14:11:14"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Sad demise of Mr. Vijaykumar Ratilal Shah (DIN: 00376570) Independent Director of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce4842e9-3624-4978-8797-8e9123c4bb4d.pdf",
            "news_date": "2025-02-27 14:12:46"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Please find attached herewith disclosure under Regulation 30 of SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de118fac-1a4a-40c4-914f-247f18433da0.pdf",
            "news_date": "2025-02-26 14:14:37"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Intimation of Investors/Analyst Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4912e021-ac78-4efb-a9df-6cda656c8221.pdf",
            "news_date": "2025-02-21 17:12:59"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a884dff3-3e6c-4d39-bdb1-e775ac396f5d.pdf",
            "news_date": "2025-01-31 16:32:28"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Transcript Of Earnings Call.",
            "news_body": "Please find attached herewith Transcript of Earnings Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3b1b58a-2571-4ae9-9de0-8b97fb4432dc.pdf",
            "news_date": "2025-01-30 12:40:00"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith Analyst/investors meet intimation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37cdf4a4-d0f9-4e3e-b039-602df3c92807.pdf",
            "news_date": "2025-01-29 17:17:06"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q3 FY2024-25 Earnings Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e34735b8-9fe6-406d-841c-2743a3c22a0b.pdf",
            "news_date": "2025-01-23 18:41:49"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Please find attached herewith Integrated Filing (Financials) for the third quarter and nine months ended 31 December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2cb1ef8-8581-4e65-85e4-4e19ae9b488f.pdf",
            "news_date": "2025-01-23 17:57:59"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "a39ae1f5-daa9-4a89-98fd-cda8484e99e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d4a2401-f8d5-40d1-bc29-a9d6a7537501.pdf",
            "news_date": "2025-01-23 14:33:57",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d4a2401-f8d5-40d1-bc29-a9d6a7537501.pdf",
            "news_date": "2025-01-23 14:33:57"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached herewith Press release.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52d3b346-3534-42c3-a5e6-34fc81c66e0b.pdf",
            "news_date": "2025-01-23 14:31:08"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024",
            "news_body": "We would wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine months ended December 31 2024.",
            "news_id": "a6ed047f-c9b4-4c07-a80d-0c191be82491",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e21e6b69-26e5-492f-b7f0-c857d3254ec8.pdf",
            "news_date": "2025-01-23 14:23:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2024",
            "news_body": "We would wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e21e6b69-26e5-492f-b7f0-c857d3254ec8.pdf",
            "news_date": "2025-01-23 14:23:13"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Glenmark Life Sciences rebrands as Alivus Life Sciences",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=263e06c8-7958-48f6-8c50-dbb0a40f50dc.pdf",
            "news_date": "2025-01-18 13:49:21"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Enclosed please find herewith the details of Earnings Call slated for Thursday January 23 2025 at 4:00 p.m.- 5:00 p.m. (IST) for your information and record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae0b6fc-9a0c-4fdd-98a9-f45552d6c1f1.pdf",
            "news_date": "2025-01-17 15:59:30"
        },
        {
            "co_code": 75599,
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "We wish to inform you that the Company has intimated its designated persons regarding the closure of trading window from December 31 2024 to January 25 2025 (both days inclusive) for the purpose of approval of unaudited financial Results for the Third quarter and nine months ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3177d96-f1c3-4abf-9baf-b57fb6da912c.pdf",
            "news_date": "2025-01-16 15:57:16"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q2 FY2024-25 Earnings Call",
            "news_id": "a144605a-5956-4343-b5d3-17cebac176a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d780dc9a-b5be-4597-953d-9748e5681e09.pdf",
            "news_date": "2024-10-25 17:44:39",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "bbaa3301-1f64-4a4a-8161-6ecf9c487901",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e76d4a86-7399-4723-be60-a7e79244454a.pdf",
            "news_date": "2024-10-24 19:32:25",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Finanacial Results For The Second Quarter And Half Year Ended 30Th September 2024.",
            "news_body": "Please find attached herewith unaudited Finacial Results for the second quarter and half year ended 30th September 2024",
            "news_id": "53889a6f-eb85-4d61-904e-90a4888bd117",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce153b4-0caf-4e40-9583-fd95c6b51220.pdf",
            "news_date": "2024-10-24 18:27:20",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Earning Calls Transcript.",
            "news_id": "ae12a374-686a-44cc-b75c-4ccb93c35f72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d99fa1-82a2-4424-b066-36565368ce9b.pdf",
            "news_date": "2024-08-02 17:40:20",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2024-25 Earnings Call.",
            "news_id": "37356cec-7ac3-4c9f-b8b3-b27d535c9c12",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be0d5d30-d90e-4438-b422-14e049b187ac.pdf",
            "news_date": "2024-07-26 17:35:31",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We are enclosing herewith the Investor Presentation - Q1 FY 24-25.",
            "news_id": "452d3d8f-746d-4f56-8ae7-ce045cad0389",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90ee7efe-a0f6-4393-9ac0-6923563905d6.pdf",
            "news_date": "2024-07-25 19:58:41",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2024",
            "news_body": "Please find attached unaudited financial result for First Quarter ended June 30, 2024",
            "news_id": "539f1ef1-e25a-4566-ae89-68686833ab6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8645a78-cbce-474a-9f94-74cb940c372e.pdf",
            "news_date": "2024-07-25 19:18:08",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith Earnings Call Transcript.",
            "news_id": "265e017e-307c-4806-8564-f4360fb1b51f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86dbe2fa-8e54-4b3b-bbfa-80979a129a5c.pdf",
            "news_date": "2024-05-03 17:14:02",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q4 FY2023-24 Earnings Call",
            "news_id": "ff65fb3a-32b3-4eb7-9ecc-4742e72f4e52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=788eded2-2410-4ba1-8159-b9f5fe42ab44.pdf",
            "news_date": "2024-04-26 16:02:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investors Presentation.",
            "news_id": "03694bad-b9e0-486a-a09f-79cd685c64bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5da7756-cb58-4feb-b494-526ce47cc641.pdf",
            "news_date": "2024-04-25 15:06:31",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results",
            "news_body": "Please Find Attached Audited Financial Results for Quarter and Year ended 31st March 2024",
            "news_id": "09069e75-8b0f-4c5f-b420-96061e5d6b70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4425b5d-9f06-471f-882b-e95c00b92ac0.pdf",
            "news_date": "2024-04-25 14:50:16",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please enclosed find herewith copy of the Investor Presentation.",
            "news_id": "d2acce50-7659-4c77-bf4b-3a98fa2e88eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90aaf027-b5fe-40b6-bd85-eee3788ff1bf.pdf",
            "news_date": "2024-03-11 18:57:37",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call",
            "news_id": "bb91180c-7a2a-45a6-89a6-0817a95d4d9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fbc8804-cd7f-430a-83c6-4ed9abb7b8a3.pdf",
            "news_date": "2024-01-31 22:34:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q3 FY2023-24 Earnings Call held on 24th January, 2024 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320240124150895.mp3",
            "news_id": "98d11902-e25a-48f0-9bed-a239b1cb0244",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd5862d-9595-4774-ad9e-89b1845962d1.pdf",
            "news_date": "2024-01-24 15:45:55",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 - FY 23-24",
            "news_id": "eeda3115-10a3-4ab7-9dad-b2e458bc1eed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c38a984-387a-4b9a-af85-304e4f9fcca0.pdf",
            "news_date": "2024-01-23 17:42:47",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Calls.",
            "news_id": "21ba04dc-2af1-4cbc-861c-2078166c115d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5eefc359-c628-4518-8e3b-054326c34319.pdf",
            "news_date": "2023-10-25 17:50:49",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2023-24 Earnings Call held on 20th October, 2023 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320231020149273.mp3",
            "news_id": "867fe84c-d1d1-4feb-9398-4ee4e7492c9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b66f0b8-80f1-4364-8c8b-57af66bf0241.pdf",
            "news_date": "2023-10-21 15:45:28",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 - FY 23-24",
            "news_id": "a54ae77a-e970-4f15-9b8c-f5e55048edd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76dc2164-9985-4914-96f7-4ddf06fb741d.pdf",
            "news_date": "2023-10-20 13:23:53",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on Friday, July 21, 2023 for the first quarter ended June 30, 2023 is available on the Company''s website. The said transcript is also attached.",
            "news_id": "f9734ced-eafc-44ae-a42f-96732a217bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d87a6b57-d63b-4ebc-bde9-c277fa6c95bb.pdf",
            "news_date": "2023-07-24 16:25:26",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Q1 FY2023-24 Earnings Call",
            "news_id": "6fc1bb26-50d6-4aa6-90b0-59acf5accb60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3dee141c-7319-47e1-8d64-492933e75a78.pdf",
            "news_date": "2023-07-21 22:20:50",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY24",
            "news_id": "883c5e52-3720-45ab-9998-443d49f7916d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3ab243f-0ac2-4c2c-b60d-de95d906488b.pdf",
            "news_date": "2023-07-21 13:13:04",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the First Quarter ended June 30, 2023",
            "news_id": "9e17558d-fc77-48bf-abaa-e12961a6bb2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fefd3e7-5eaa-4dcd-99c9-f5ab661eef6d.pdf",
            "news_date": "2023-07-21 12:55:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, April 28, 2023 for the Fourth quarter and year ended March 31, 2023 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Earnings%20Call%20Transcript_28_April_2023.pdfThe said transcript is also attached.",
            "news_id": "6e29bfe7-d587-4ed1-813c-d81ab7e98c7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec41a636-1e55-4541-8330-ce401d102453.pdf",
            "news_date": "2023-05-02 14:21:17",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q4 FY2022-23 Earnings Call held on 28th April, 2023 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320230428146371.mp3",
            "news_id": "2efeaa1e-8d77-4127-873d-769e4a0eab1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=429e2790-dbf6-4048-a36c-ae1779fcf5b9.pdf",
            "news_date": "2023-04-28 15:13:16",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "8cb99891-1dd3-42c8-9ada-a2a42ed3ddf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c855912-7c32-4231-80fb-a2bf4088b181.pdf",
            "news_date": "2023-04-27 18:19:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Financial Results for the quarter and year ended March 31, 2023",
            "news_id": "fd9d8641-5a97-4b2e-bc20-edb95e62bae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=950f6c83-cc58-4bb4-a91f-78ad1921cf02.pdf",
            "news_date": "2023-04-27 17:40:32",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, January 27, 2023 for the Third quarter and Nine Months ended December 31, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Glenmark Life Sciences-Earnings Call Transcript-Jan- 27_2023.pdfThe said transcript is also attached.",
            "news_id": "145b924f-76ee-465b-9dec-10715fd9e211",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885a7dec-e235-431a-bb5d-eb0eac09370c.pdf",
            "news_date": "2023-02-01 11:13:42",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Q3 FY2022-23 Earnings Call",
            "news_id": "3c5d03f2-bed6-4772-aa92-5e6f23f10345",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773b40a0-f013-4e8c-bf0f-2e7d2de9334c.pdf",
            "news_date": "2023-01-28 15:58:35",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "9335b056-d535-4b8c-ae7a-e627698db306",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e69fa3c-e575-4997-a596-b46ac5ef7de5.pdf",
            "news_date": "2023-01-27 13:27:28",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2022<BR> <BR>",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2022.<BR> <BR> The said meeting of the Board commenced at 11.00 a.m. and concluded at 12.30 p.m. <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "b84033f4-3bb0-486d-9580-1dd05b0c655b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ea3f3af-aee5-4f92-9f24-afa494df94d4.pdf",
            "news_date": "2023-01-27 12:55:50",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation - Glenmark Life Sciences Limited Investor Day 2022",
            "news_id": "5ea12521-1828-457f-9c26-5c97cf9f7cf0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fca0df87-b624-46b2-ae30-2337ca312407.pdf",
            "news_date": "2022-11-17 18:33:48",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Further to our communication dated November 11, 2022, attached is a copy of the presentation to be made at Glenmark Life Sciences Limited - Investor Day 2022 which is scheduled today at 15:45 IST in Mumbai.Kindly take the same on record and acknowledge receipt.",
            "news_id": "da62f877-3d1f-4ed7-935a-4c1d7e5abde0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3230e07f-4486-41c8-985e-f19bb2bfd40d.pdf",
            "news_date": "2022-11-17 15:33:04",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI   (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022.Request you to kindly take the same on record.",
            "news_id": "587f127d-058d-4345-9c1c-55e2fbc3f3c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c43edee5-9584-463e-a468-c591daac7d47.pdf",
            "news_date": "2022-11-04 18:22:13",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, October 21, 2022 for the quarter and half year ended September 30, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q2%20FY2022-23.pdfThe said transcript is also attached.",
            "news_id": "00f9ae3f-199a-4369-8a3d-c4515a8554e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4479f3b7-f07d-40e3-a42e-c65938e2f552.pdf",
            "news_date": "2022-10-27 11:19:17",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at:https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3Request you to kindly take the same on record.",
            "news_id": "08707d7c-d85e-42db-be98-b4a22e9957ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13fe9a3a-87ed-4214-94b7-865b4ee8414e.pdf",
            "news_date": "2022-10-22 15:06:09",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "88d74866-a8a1-4398-95b8-7e5549deeb9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=528a8126-0e2f-4d0c-8473-8c0e7ae51f0e.pdf",
            "news_date": "2022-10-21 13:46:48",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Second Quarter And Half Year Ended September 30, 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2022.<BR> <BR> The said meeting of the Board commenced at 11.30 a.m. and concluded at 01.10 p.m. <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR>",
            "news_id": "5a424736-bd84-483b-84d8-a86c3219b2cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12560b24-eba9-48ca-84e7-eb65e30941aa.pdf",
            "news_date": "2022-10-21 13:30:14",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the transcript of the Earnings call held on Friday, 5th August, 2022 for the quarter ended June 30, 2022 is available on the Company's website at:https://www.glenmarklifesciences.com/pdf/Transcript%20of%20Earnings%20Concall%20Q1%20FY2022-23.pdfRequest you to kindly take the same on record.",
            "news_id": "b525e4de-d452-426d-b725-8835125f8d0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d6593be-3b15-44bf-824a-865d6bd4b634.pdf",
            "news_date": "2022-08-08 16:39:55",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Q1 FY2022-23 Earnings Call Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of the Q1 FY2022-23 Earnings Call held on 5th August, 2022 on the website of the Company at:  https://www.glenmarklifesciences.com/pdf/GLE9320220805142632.mp3",
            "news_id": "f925101b-43c5-46d0-88ed-71d81176a2aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=604f198e-f3de-493a-8a83-572dcd804991.pdf",
            "news_date": "2022-08-05 16:15:03",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "4d8c0076-2b0c-42a3-92b6-008025d5f503",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb44fed9-6112-4d3a-94f1-40a8c614607d.pdf",
            "news_date": "2022-08-04 18:54:02",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2022.<BR> <BR> The said meeting of the Board commenced at 3.30 p.m. and concluded at 6.05 p.m.<BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. <BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR>",
            "news_id": "4d4764e7-fecf-4e50-90cb-5277930bd741",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=908ac955-d75a-40ea-a7f8-368430524c01.pdf",
            "news_date": "2022-08-04 18:21:14",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI   (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended March 31, 2022, in the required format.",
            "news_id": "28ac6be4-a811-4355-8051-ce92fe357b2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b66fd59-bf5c-40d6-b92a-a67024e71660.pdf",
            "news_date": "2022-05-31 17:43:11",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recordings Of Q4 & FY22 Earnings Call",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 & FY22 Earnings Call held on April 21, 2022, on our investor website : https://www.glenmarklifesciences.com/financial-results.php under Financial Results.We request you to take note and host the same on your website.",
            "news_id": "b4af379c-0297-4027-b366-94e8cb6f38f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59bc92dd-8556-45c3-9832-8065c8545a88.pdf",
            "news_date": "2022-04-22 10:30:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "e44a8f16-4a4d-4a96-a2a0-6c122402cd91",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6987bb95-c3c4-4f0a-98d4-d4f006537bab.pdf",
            "news_date": "2022-04-20 20:26:24",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting - April 20, 2022",
            "news_body": "The Board of Glenmark Life Sciences Limited at its meeting held on April 20, 2022, has, inter alia, considered and approved:<BR> <BR> 1. The Audited Financial Results for the Year ended March 31, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The copy of the said results together with Management Discussion & Analysis, Press Release, Auditors Report and Declaration of unmodified opinion are enclosed herewith. These are also being made available on the website of the Company at www.glenmarklifesciences.com.<BR>  <BR> 2. Recommended final Dividend of Rs. 10.50 per share (face value of Rs. 2/- each) on the Equity Share Capital of the Company for the financial year 2021 - 22 subject to the approval of the Shareholders at the ensuing Annual General Meeting.<BR>",
            "news_id": "833f7797-8ecb-4713-b181-db904be2784c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c1ea30f-8d42-444c-b149-d2647efe9edf.pdf",
            "news_date": "2022-04-20 19:35:25",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.",
            "news_id": "540b83f5-2de3-467b-92fa-4f3ab503788d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cca1bea9-a517-4b0d-b76a-15025d40fec5.pdf",
            "news_date": "2022-02-08 19:22:51",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the Third<BR> Quarter and Nine Months ended December 31, 2021.<BR> <BR> The said meeting of the Board commenced at 3.30 p.m. and concluded at 6.20 p.m. <BR> <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.",
            "news_id": "f4f86394-fa7a-47f0-8f15-9b55b35e5764",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de065bcf-cc57-4970-9292-63638122b9be.pdf",
            "news_date": "2022-02-08 18:44:19",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.<BR>",
            "news_id": "5ffde5de-7655-44a4-b2e6-370a4931cac0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fc23f73-8248-4c98-8586-ed763b498515.pdf",
            "news_date": "2021-11-10 20:53:47",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting -10Th November, 2021",
            "news_body": "The Board of Directors of Glenmark Life Sciences Limited at its meeting held on November 10, 2021, has, inter alia, considered and approved:<BR> Financial Result:<BR> 1. The Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith. These are also<BR> being made available on the website of the Company at www.glenmarkllfesciences.com<BR> Interim Dividend:<BR> 2. Declared an interim dividend of Rs. 10.5/-per equity share of face value of Rs.2/ each for the financial year ending 31st March, 2022. Record date for the purpose of determining<BR> the entitlement of the shareholders for the interim dividend has been fixed as 23rd, November 2021, and dividend will be paid to the shareholders on or after 3rd December, 2021.",
            "news_id": "1157e76b-263f-473a-9705-db1954aba19d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7e43b63-4442-4e91-9988-704e0fc7cb70.pdf",
            "news_date": "2021-11-10 19:29:05",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2021.<BR> <BR> The said meeting of the Board commenced at 10.00 a.m. and concluded at 12.10 p.m.   <BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "b3b942c4-5902-42f5-97a6-beb39935a76b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5bce429-eef8-460a-a323-aaa62270e9e2.pdf",
            "news_date": "2021-08-13 13:19:57",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ALIVUS",
            "disp": "Alivus Life Sciences",
            "bse_code": 543322,
            "isin": "INE03Q201024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The First Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that the Board at its meeting held today approved the Unaudited Financial Results for the First Quarter ended June 30, 2021.<BR> <BR> The said meeting of the Board commenced at 10.00 a.m. and concluded at 12.10 p.m.<BR>  <BR> The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.<BR> <BR> These are also being made available on the website of the Company at www.glenmarklifesciences.com<BR> <BR> You are requested to take the same on record.<BR>",
            "news_id": "2cb403e1-c5a9-4ac8-9f99-d2469f9576ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fae44e0-b03a-4040-b77b-527d427bd1fa.pdf",
            "news_date": "2021-08-13 13:16:15",
            "seo": "glenmark-life-science-ltd",
            "ltp": 929.4,
            "ch": -22.350000000000023,
            "pch": -2.348305752561074,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 5265,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}